Drug stocks sink as backlash against price hikes hits bottom lines
The backlash against steep pharmaceutical price hikes over the last year has notoriously taken down individual drug companies — Mylan,
Read More
sink
The backlash against steep pharmaceutical price hikes over the last year has notoriously taken down individual drug companies — Mylan,
Read More